Department of Otolaryngology and Head and Neck Surgery, Charité-Universitätsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.
Crit Rev Oncol Hematol. 2012 Mar;81(3):224-40. doi: 10.1016/j.critrevonc.2011.03.004. Epub 2011 Apr 20.
The initiation and metastasis of head and neck squamous cell carcinomas (HNSCC) and other cancers have recently been related to the presence of cancer stem cells (CSC). CSC are cancer initiating, sustaining and are mostly quiescent. Specific markers that vary considerably depending on tumor type or tissue of origin characterize putative CSC. Compared to the bulk tumor mass, CSC are less sensitive to chemo- and radiotherapy and may also have low immunogenicity. Therapeutic targeting of CSC may improve clinical outcome of HNSCC which has two distinct etiologies: infection of epithelial stem cells by high-risk types of the human papillomavirus, or long-term tobacco and alcohol abuse. Recent knowledge on the role of CSC in HNSCC is reviewed and where necessary parallels to CSC of other origin are drawn to give a more comprehensive picture.
头颈部鳞状细胞癌(HNSCC)和其他癌症的发生和转移最近与癌症干细胞(CSC)的存在有关。CSC 是癌症的起始、维持者,且大多处于静止状态。特定的标记物因肿瘤类型或起源组织而异,这些标记物可以用来鉴定 CSC。与肿瘤的大部分肿块相比,CSC 对化疗和放疗的敏感性较低,而且免疫原性也可能较低。针对 CSC 的治疗可能会改善 HNSCC 的临床结果,HNSCC 有两种不同的病因:高危型人乳头瘤病毒感染上皮干细胞,或长期吸烟和酗酒。本文回顾了 CSC 在 HNSCC 中的作用,并在必要时与其他来源的 CSC 进行了比较,以更全面地了解 CSC。